Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases

J Neuroinflammation. 2022 Jul 14;19(1):183. doi: 10.1186/s12974-022-02547-2.

Abstract

Pyroptosis is a programmed cell death characterized by swift plasma membrane disruption and subsequent release of cellular contents and pro-inflammatory mediators (cytokines), including IL-1β and IL-18. It differs from other types of programmed cell death such as apoptosis, autophagy, necroptosis, ferroptosis, and NETosis in terms of its morphology and mechanism. As a recently discovered form of cell death, pyroptosis has been demonstrated to be involved in the progression of multiple diseases. Recent studies have also suggested that pyroptosis is linked to various ocular diseases. In this review, we systematically summarized and discussed recent scientific discoveries of the involvement of pyroptosis in common ocular diseases, including diabetic retinopathy, age-related macular degeneration, AIDS-related human cytomegalovirus retinitis, glaucoma, dry eye disease, keratitis, uveitis, and cataract. We also organized new and emerging evidence suggesting that pyroptosis signaling pathways may be potential therapeutic targets in ocular diseases, hoping to provide a summary of overall intervention strategies and relevant multi-dimensional evaluations for various ocular diseases, as well as offer valuable ideas for further research and development from the perspective of pyroptosis.

Keywords: Caspase-1; Caspase-4/5/11; Eye; Gasdermin; Inflammasome; Pyroptosis.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Humans
  • Inflammasomes* / metabolism
  • Inflammation Mediators
  • Necroptosis
  • Pyroptosis* / physiology

Substances

  • Inflammasomes
  • Inflammation Mediators